Naoharu Takano

Tokyo Medical University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index3.0kcitations128works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(57), RNA modifications and cancer(55), Cancer, Lipids, and Metabolism(50), Cancer, Hypoxia, and Metabolism(23), Autophagy in Disease and Therapy(12)

Publications128 total

Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway
PLoS ONE·2024· 4 citedOpen Access
Supplementary Fig.S1 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Methods and References from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S4 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S13 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S2 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S3 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S6 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S15 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S5 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S8 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S9 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Data from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S16 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S12 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Table S1 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S18 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S7 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S17 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
Supplementary Fig.S1 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Keisuke Miyazawa(19), Hiromi Kazama(15), Masaki Hiramoto(15), Makoto Suematsu(12), Hirotsugu Hino(11), Gregg L. Semenza(10), Shota Moriya(10), Takehiro Yamamoto(9), Takayuki Takahashi(9), Daniele M. Gilkes(8), Takako Hishiki(8), Weibo Luo(7), Tomomi Matsuura(7), Hiroko Kokuba(7), Lisha Xiang(6), Pallavi Chaturvedi(6), Akiko Kubo(6), Kiyoaki Tsukahara(6), Tetsu Hayashida(5), Yohei Masugi(5)